|
| Giorgio Seano | Massachusetts General Hospital and Harvard Medical School, University of Melbourne, Australia (EIA) Novartis Institutes for BioMedical Research, MA (NDK) Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Massachusetts General Hospital Biostatistics Center, NYU Langone Medical Center and Medical School, Dana-Farber Cancer Institute, Harvard Medical School, MA (SG) Tokai Pharmaceuticals, Inc. |
| Dianne M Finkelstein | Massachusetts General Hospital and Harvard Medical School, University of Melbourne, Australia (EIA) Novartis Institutes for BioMedical Research, MA (NDK) Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Massachusetts General Hospital Biostatistics Center, NYU Langone Medical Center and Medical School, Dana-Farber Cancer Institute, Harvard Medical School, MA (SG) Tokai Pharmaceuticals, Inc. |
| Rakesh K Jain | Massachusetts General Hospital and Harvard Medical School, University of Melbourne, Australia (EIA) Novartis Institutes for BioMedical Research, MA (NDK) Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney, Massachusetts General Hospital Biostatistics Center, NYU Langone Medical Center and Medical School, Dana-Farber Cancer Institute, Harvard Medical School, MA (SG) Tokai Pharmaceuticals, Inc. |